Evidence map›Paper›PMID 39378335›Full record

ArticleBrain : a journal of neurology2025

Somatic instability of the FGF14-SCA27B GAA•TTC repeat reveals a marked expansion bias in the cerebellum.

David Pellerin, Jean-Loup Méreaux, Susana Boluda, Matt C Danzi, Marie-Josée Dicaire, Claire-Sophie Davoine, David Genis, Guinevere Spurdens, Catherine Ashton, Jillian M Hammond and 27 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. CGG Repeat Expansion in GIPC1 is Associated with Childhood-Onset Hereditary Ataxia.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  3. Review
  4. Long-read sequencing reveals extensivebioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Exploration of Neurodegenerative Diseases Using Long-Read Sequencing and Optical Genome Mapping Technologies.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

David PellerinDr John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Jean-Loup MéreauxSorbonne Université, Institut du Cerveau-Paris Brain Institute- ICM, Inserm, CNRS, APHP, University Hospital Pitié-Salpêtrière, F-75013 Paris, France.
Susana BoludaSorbonne Université, Institut du Cerveau-Paris Brain Institute- ICM, Inserm, CNRS, APHP, University Hospital Pitié-Salpêtrière, F-75013 Paris, France.
Matt C DanziDr John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Marie-Josée DicaireDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada.
Claire-Sophie DavoineSorbonne Université, Institut du Cerveau-Paris Brain Institute- ICM, Inserm, CNRS, APHP, University Hospital Pitié-Salpêtrière, F-75013 Paris, France.
David GenisAtaxia and Hereditary Spastic Paraplegia Unit, Service of Neurology, Hospital Universitari de Girona Dr. Josep Trueta (ICS) & Hospital Santa Caterina IAS, Institut d'Investigació Biomèdica de Girona (IDIBGI), 17007 Girona, Spain.
Guinevere SpurdensDr John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Catherine AshtonDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada.ORCID 0000-0001-8042-6180
Jillian M HammondGenomics and Inherited Disease Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
Brandon J GerhartDepartment of Neurology, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-8823, USA.
Viorica ChelbanDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London WC1N 3BG, UK.ORCID 0000-0002-5817-6290
Phuong U LeDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada.
Maryam SafisamghabadiDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada.
Christopher YanickDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Hamin LeeDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London WC1N 3BG, UK.
Sathiji K NageshwaranDepartment of Psychiatry, Friedman Brain Institute Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA.
Gabriel Matos-RodriguesLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Zane JaunmuktaneDivision of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London WC1N 3BG, UK.
Kevin PetreccaDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada.
Schahram AkbarianDepartment of Psychiatry, Friedman Brain Institute Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA.
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Karen UsdinLaboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Mathilde RenaudINSERM-U1256 NGERE, Université de Lorraine, 54500 Nancy, France.
Céline BonnetINSERM-U1256 NGERE, Université de Lorraine, 54500 Nancy, France.
Gianina RavenscroftHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Perth, WA 6009, Australia.
Mario A SaportaDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Jill S NapieralaDepartment of Neurology, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-8823, USA.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London WC1N 3BG, UK.ORCID 0000-0002-2866-7777
Ira W DevesonGenomics and Inherited Disease Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.ORCID 0000-0003-3861-0472
Marek NapieralaDepartment of Neurology, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-8823, USA.ORCID 0000-0002-9987-0641
Alexis BriceSorbonne Université, Institut du Cerveau-Paris Brain Institute- ICM, Inserm, CNRS, APHP, University Hospital Pitié-Salpêtrière, F-75013 Paris, France.
Laura Molina PorcelAlzheimer's Disease and other Cognitive Disorders Unit, Service of Neurology, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, 08036 Barcelona, Spain.
Danielle SeilheanSorbonne Université, Institut du Cerveau-Paris Brain Institute- ICM, Inserm, CNRS, APHP, University Hospital Pitié-Salpêtrière, F-75013 Paris, France.
Stephan ZuchnerDr John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0002-8498-5235
Alexandra DurrSorbonne Université, Institut du Cerveau-Paris Brain Institute- ICM, Inserm, CNRS, APHP, University Hospital Pitié-Salpêtrière, F-75013 Paris, France.ORCID 0000-0002-8921-7104
Bernard BraisDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada.ORCID 0000-0003-1394-3561

Funding

GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
Single Chromatin Fiber Sequencing and Longitudinal Epigenomic Profiling in HIV+ Brain Cells Exposed to Narcotic and StimulantDP1DA056018 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Schahram Akbarian · 2022 to 2026
$5.9M
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIAR01NS081366 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI NAPIERALA, MAREK · 2012 to 2021
$3.7M
Alzheimer's Research UKAssociation of British Neurologists 540868Ataxia UKCIHR 189963Fidelity TrustFondation Groupe MonacoFondation pour la Recherche Médicale 13338Friedreich's Ataxia Research AllianceGuarantors of Brain 565908King Baudouin FoundationManx MSA TrustMedical Research CouncilMedical Research Future Fund 1173594Michael J Fox FoundationMSA CoalitionMSA TrustNational Health and Medical Research CouncilNational Institute for Health and Care ResearchNational Institutes of Neurological Disorders and Stroke NS081366NCI NIH HHS HHSN261201500003NIDA NIH HHS DP1 DA056018NIDA NIH HHS DP1DA056018NIH HHSNIH National Institutes of Neurological Disorders and Stroke 2R01NS072248-11A1NINDS NIH HHS R01 NS072248NINDS NIH HHS R01 NS081366Rosetrees TrustUCLH Biomedical Research CentreUCLH/UCL Biomedical Research CentreWellcome Trust
6 · The paper itself

Abstract

Spinocerebellar ataxia 27B (SCA27B) is a common autosomal dominant ataxia caused by an intronic GAA•TTC repeat expansion in FGF14. Neuropathological studies have shown that neuronal loss is largely restricted to the cerebellum. Although the repeat locus is highly unstable during intergenerational transmission, it remains unknown whether it exhibits cerebral mosaicism and progressive instability throughout life. We conducted an analysis of the FGF14 GAA•TTC repeat somatic instability across 156 serial blood samples from 69 individuals, fibroblasts, induced pluripotent stem cells and post-mortem brain tissues from six controls and six patients with SCA27B, alongside methylation profiling using targeted long-read sequencing. Peripheral tissues exhibited minimal somatic instability, which did not significantly change over periods of more than 20 years. In post-mortem brains, the GAA•TTC repeat was remarkably stable across all regions, except in the cerebellar hemispheres and vermis. The levels of somatic expansion in the cerebellar hemispheres and vermis were, on average, 3.15 and 2.72 times greater relative to other examined brain regions, respectively. Additionally, levels of somatic expansion in the brain increased with repeat length and tissue expression of FGF14. We found no significant difference in methylation of wild-type and expanded FGF14 alleles in post-mortem cerebellar hemispheres between patients and controls. In conclusion, our study revealed that the FGF14 GAA•TTC repeat exhibits a cerebellar-specific expansion bias, which may explain the pure cerebellar involvement in SCA27B.

Indexed as

CerebellumFibroblast Growth FactorsSpinocerebellar AtaxiasTrinucleotide Repeat ExpansionAdultAgedDNA MethylationFemaleGenomic InstabilityHumansMaleMiddle Agedfibroblast growth factor 14Fibroblast Growth FactorsGAA-FGF14 ataxiamosaicismrepeat expansionrepeat expansion disorderSCA27Bspinocerebellar ataxia 27B

Identifiers

PMID39378335
PMCPMC11969470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.